Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Women of color in Northern Manhattan view hair care as important to their identity and culture, and education on harmful chemicals in hair products is needed.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Women are more likely than men to hide their age due to societal pressures.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

Women know more about androgenetic alopecia than men.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

Women with Polycystic Ovary Syndrome have a higher chance of getting depressed.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Women with and without PCOS show no significant differences in psychopathic traits.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Women who had cancer treatment feel both positive and negative about their bodies.

Women with androgenetic alopecia have lower zinc and iron levels.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Women with menstrual dysfunction often have deficiencies in magnesium, iron, and vitamin D.

Women with PCOS have different body composition and some metabolic differences compared to healthy women.

The document concludes that women's health needs a holistic approach, considering all life stages, promoting lifestyle changes, regular exercise, proper diet, and vaccinations, with health professionals playing a key role in education and guidance.

Women with PCOS are much more likely to experience depression.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.